enthesitis-related juvenile idiopathic arthritis
ORPHA: 854382 Treatments Available
Available Treatments (2)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| etanercept Cold Chain | subcutaneous injection 25mg, 50mg prefilled syringe; 50mg/mL autoinjector | FDA Approved | 10 | 10d |
| Infliximab Cold Chain | Intravenous infusion | FDA Approved | 5 | 14d |
Clinical Presentation
Signs and symptoms associated with enthesitis-related juvenile idiopathic arthritis, sourced from HPO and Orphanet clinical annotations.
OligoarthritisAbnormal fascia morphologyAbnormal lumbar spine morphologyAbnormal heart morphologyAbnormal foot morphologyAbnormal metatarsal morphologyAbnormality of the wristAbnormal shoulder morphologyAbnormality of the cervical spineArthritisArthralgiaEnthesitisAbnormality of the vertebral columnAbnormal hip joint morphologyAbnormality of the ankleBack painThickened Achilles tendonKnee osteoarthritisAbnormality of the calcaneusHip osteoarthritisSacroiliac arthritisAbnormal femoral neck/head morphologyLimited mobility of proximal interphalangeal jointNongranulomatous uveitisAbnormality of the elbowAbnormal skeletal morphologyAbnormal metacarpophalangeal joint morphologyAnterior uveitisFinger dactylitisAbnormal thoracic spine morphologyIgA deposition in the glomerulusMitral valve prolapseAortic regurgitationDilatation of the ventricular cavity
Classification & Codes
Orphanet Code
ORPHA:85438enthesitis-related juvenile idiopathic arthritis
| Orphanet | ORPHA:85438 |
| Treatments | 2 drug(s) |
| Symptoms on record | 34 signs |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO